Author

C. Martínez-Laperche

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

EZH2 mutation status predicts inferior outcomes after bendamustine‐based immunochemotherapy in frontline follicular lymphoma: A GELTAMO multicenter validation study

Follicular lymphoma (FL) is the most common indolent lymphoma, 1,2 a biologically and clinically heterogeneous entity with a diverse genetic landscape and characterized by slowly progressive but relapsing clinical course. 3 The t(14;18) translocation driving BCL ‐ 2 overexpression is present in 85% – 90% of patients 4...

C. Martínez-Laperche, Pilar Lancho-Lavilla, Antonio Gutiérrez et al. · HemaSphere · 0 citations

Review Oct 2026

Molecular Underpinnings and Prevalence of Donor Cell-Derived Hematologic Neoplasms among Spanish Transplantation Centers.

Donor cell-derived hematologic neoplasm (DDHN) is defined as a de novo hematologic malignancy originated from transplanted donor stem cells, distinct from the original recipient's disease (ORD). Its prevalence and biological mechanisms remain poorly defined. We conducted a nationwide study to estimate the prevalence of...

Maria Gabarrós-Subirà, H. Pomares, F. Beas et al. · Blood · 0 citations